SCHEMBL6012264

SCHEMBL6012264

O=C(NC1CCCCC1)c1cccnc1OC1CCSCC1

nearest known ligand 0.60

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CNR2 P34972 6/20 0.60
CNR1 P21554 5/20 0.60
ALDH1A1 P00352 3/20 0.56
KDM4E B2RXH2 2/20 0.56
GAA P10253 1/20 0.56
RAB9A P51151 3/20 0.54
MEN1 O00255 1/20 0.53
CYP1A2 P05177 1/20 0.53
CYP3A4 P08684 1/20 0.53
CYP2C9 P11712 1/20 0.53
CYP2C19 P33261 1/20 0.53
KMT2A Q03164 1/20 0.53
HSD11B1 P28845 1/20 0.49
TYK2 P29597 2/20 0.48
NPC1 O15118 2/20 0.47
HTT P42858 2/20 0.47
LMNA P02545 1/20 0.47
HPGD P15428 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8299116 0.89 CNR2 (0.48) CNR2CNR1ALDH1A1KDM4EGAA
Hydrochloric Acid SCHEMBL4185132 0.88 CNR2 (0.47) CNR2CNR1ALDH1A1KDM4EGAA
SCHEMBL4200640 0.84 CNR2 (0.47) CNR2CNR1RAB9ATYK2
SCHEMBL13929052 0.84 CNR2 (0.47) CNR2CNR1RAB9ATYK2
SCHEMBL6012159 0.79 ROCK2 (0.49) RAB9A
SCHEMBL14615139 0.79 GRM4 (0.42) ALDH1A1
SCHEMBL6323279 0.78 CNR2 (0.44) CNR2CNR1ALDH1A1TYK2
SCHEMBL4200635 0.78 CNR2 (0.44) CNR2CNR1ALDH1A1TYK2
SCHEMBL5551331 0.77 CNR2 (0.39) CNR2CNR1ALDH1A1TYK2LMNA
SCHEMBL13929028 0.76 L3MBTL1 (0.53) CNR2CNR1ALDH1A1KDM4EMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1651641-A1 NICOTINAMIDE DERIVATIVES USEFUL AS PDE4 INHIBITORS Pfizer Limited (GB) 2006-05-03 EP disclosed
WO-2005009995-A1 NICOTINAMIDE DERIVATIVES USEFUL AS PDE4 INHIBITORS PFIZER LIMITED (GB) 2005-02-03 WO disclosed